Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
44 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Vrijwillige ontbinding – vereffening according to the CBE.
Financials
Financial year 2025
DAMACINE from Brussel, company number BE0402891973, closed financial year 2025 with a result of € 682 after tax. For that financial year DAMACINE recorded a gross margin of € -2,318 and equity of € 83,347. Compared with financial year 2024, the result moved from € 96 to € 682. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2025.
€ 83,347
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 682
▲ € 586 vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -225,582.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,574
▼ 44% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -2,628 | € 170 | € -2,904 | € -2,318 | ▲ € 586 |
| Profit after taxes | € -17,649 | € 3,170 | € 96 | € 682 | ▲ € 586 |
| Equity | € 79,398 | € 82,568 | € 82,664 | € 83,347 | ▲ 1% |
| Total debts | € 42,669 | € 42,300 | € 45,649 | € 48,049 | ▲ 5% |
| Retained profit | € -229,530 | € -226,360 | € -226,264 | € -225,582 | |
| Balance sheet total | € 122,068 | € 124,869 | € 128,314 | € 131,395 | ▲ 2% |
Key figures of DAMACINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to DAMACINE?
What happened at DAMACINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
DAMACINE is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.
- New annual accounts for financial year 2025: profit of € 682 (▲ € 586 vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Brussel. KBO
In short
From € 17,649 loss in 2022 to € 682 profit in 2025.
Best year ever: 2023, with € 3,170 profit.
Management
Behind DAMACINE is JACQUES VENENCIE.
Directors
According to the 2025 annual accounts
JACQUES VENENCIE
Managing director
Establishments
Establishment units
Physical locations of this company
Kunstlaan 24 box 11
1000 Brussel
Predikherenstraat 8
1000 Brussel
Active since 1 March 1953
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 44 companies are registered at this address.
All companies at this address →Compagnie des Sélectionneurs de Vins Fins et Spiritueux
Vinothèque Internationale
Lomasaari Sauna
pollen
Clinique dentaire des Arts
€ 410,769 gross margin · 2025
+39 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0402.891.973
- VAT number
- BE 0402.891.973
- Registered office
- Kunstlaan 24 bus 11, 1000 Brussel
- Names & denominations
- DAMACINE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Vrijwillige ontbinding – vereffening
- Start date
- 1 January 1968
- Peppol
- Not registered